Intervertebral disc degeneration and associated back pain are relatively common but sparsely understood conditions, affecting over 70% of the population during some point of life. Disc degeneration is often associated with a loss of nucleus pulposus (NP) cells. Genetic mouse models offer convenient avenues to understand the cellular and molecular regulation of the disc during its formation, growth, maintenance, and aging. 
Each IVD has three main components; nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplates (EP). The proteoglycan-rich NP is located in the center of each IVD and surrounded by orthogonal layers of collagen-rich AF. A pair of cartilaginous EP sandwich the NP and AF and connect the IVD to the vertebral growth plate (GP). Healthy IVDs produce abundant extracellular matrix molecules that play a vital role in the maintenance of its structure and function (Antoniou et al., 1996; Mwale, 2013) . IVDs are the massive avascular structures in the body. The nutrients and systemic factors diffuse into the IVD through the vertebral GP and EP (Urban, Holm, & Maroudas, 1978) . However, with aging, the EP undergoes mineralization and further slows the inflow of nutrients and systemic factors into the IVD, particularly in NP area, leading to IVD degeneration (Urban & Winlove, 2007; Wong et al., 2019) .
Development of the mouse as a model system has been crucial in elucidating the development and pathophysiology of the IVD (reviewed by . The genetic mouse models are not only instrumental in establishing the embryonic origin of the different components of the IVDs (Choi, Cohn, & Harfe, 2008; McCann, Tamplin, Rossant, & Seguin, 2012; Sugimoto, Takimoto, Hiraki, & Shukunami, 2013) but also offer robust approaches for elucidating the role of specific genes and pathways during IVD development, aging or degeneration (Alkhatib, Liu, & Serra, 2018; Alvarez-Garcia et al., 2018; Bonavita, Vincent, Pinelli, & Dahia, 2018; Choi, Lee, & Harfe, 2012; Sohn, Cox, Chen, & Serra, 2010) . NP cells have been the main focus of research related to IVD biology, mainly because they are descendant of the embryonic notochord, a source of developmentally critical signaling ligands, crucial for maintenance of IVD homeostasis, and their loss with age or herniation is one of the causes of IVD degeneration and back pain (reviewed by . Hence, to target approaches towards NP cells for degenerative disc disease and back pain, it is crucial to precisely determine the role of these cells in the maintenance as well as the regeneration of the IVD. The Cre/LoxP system offers the convenience of a site-specific recombinase technique to carry out gene targeting in the DNA of the cells that express the gene driving Cre.
The tamoxifen (Tam) mediated induction of Cre in the modified
CreER, or CreERT2 transgene offers the additional advantage to regulate recombination of the target gene with time, and in specific tissues. However, despite the innovative and technological advancements in mouse genetic approaches, the application of such robust genetic approaches in IVD biology and disease had been modest. The currently available driver lines to target conditional alleles in the NP cells are the non-inducible Noto
Cre (McCann et al., 2012) , Shh
Cre (Harfe et al., 2004) , and Foxa2 Cre (Uetzmann, Burtscher, & Lickert, 2008) alleles, or Tam-inducible Agc1 CreERT2 (Henry et al., 2009 ),
Col2a1
CreERT2 (Chen et al., 2007) , and Col2a1 CreER (Nakamura, Nguyen, & Mackem, 2006) . And, the Noto Cre (Bedore et al., 2013; McCann et al., 2012) , Shh Cre (Winkler, Mahoney, Sinner, Wylie, & Dahia, 2014; Wu et al., 2013) , Foxa2
Cre (Merceron et al., 2014; Uetzmann et al., 2008) , Agc1 CreERT2 (Alkhatib et al., 2018; AlvarezGarcia et al., 2018; Henry et al., 2009; Liao et al., 2019; Novais, Diekman, Shapiro, & Risbud, 2019) , and Col2a1 CreERT2 (Chen et al., 2007; Zheng et al., 2018) alleles have been used to understand the development, regulation, and aging of the mouse NP cells in the IVD.
However, none of these driver lines are appropriate to target NP cells during the postnatal stages due to the constraint of spatial and temporal regulation of their action, and specificity to the NP cells. (Barrionuevo, Taketo, Scherer, & Kispert, 2006) . Expression of KRT19 has been reported in the NP cells of various model systems including rat (Lee et al., 2007) , bovine (Minogue, Richardson, Zeef, Freemont, & Hoyland, 2010) , human (Minogue et al., 2010; Weiler et al., 2010) , and mouse (Dahia, Mahoney, & Wylie, 2012) . Also, KRT19 is considered a molecular marker of NP cells . Results from previous studies showed that all NP cells of neonatal mouse lumbar IVDs are positive for KRT19 immunostaining (Dahia et al., 2012) . Moreover, NP cells from a year-old mouse continue to express Krt19 messenger RNA (mRNA), although its expression declined with age (Winkler et al., 2014) . A Tam-inducible Cre constructed under the promoter of Krt19 is available (also known as CK19 CreERT and Krt19 tm1(cre/ERT)Ggu /J; Means, Xu, Zhao, Ray, & Gu, 2008 CreERT allele are based on the current literature on mouse model system to understand the role of NP cells in the postnatal IVD (Alkhatib et al., 2018; Alvarez-Garcia et al., 2018; Bonavita et al., 2018; Dahia et al., 2012; Vincent et al., 2019; Wu et al., 2013) .
| METHODS

| Mice
All mice used in the study were maintained in adherence with the guidelines delineated by the National Institutes of Health Guide for [Madisen et al., 2010] ) mice lines were used in the study. The genotypes were confirmed by polymerase chain reaction using genomic DNA from the toe or tail biopsy of neonatal mice, and using allele-specific primers as previously published (Madisen et al., 2010; Means et al., 2008; Muzumdar et al., 2007) . Tamoxifen (T5648; Sigma-Aldrich) was prepared in warm corn oil (20 mg/ml) and dissolved by overnight incubation in a shaker at 37°C. Previous studies show rapid and robust recombination following oral gavage of tamoxifen in adult mice (Park et al., 2008) . Also, repeated intraperitoneal injections could result in sterile peritonitis due to the accumulation of oil in the peritoneal cavity of the mice (Whitfield, Littlewood, & Soucek, 2015) .
Hence, for skeletally mature mice tamoxifen was administered by oral gavage at a dose of 200 µg/g body weight (Bowers et al., 2012; Lapinski et al., 2007; Lapinski et al., 2012) , three times and 1 day apart. In neonates, tamoxifen was injected subcutaneously or intraperitoneally at a dose of 200 µg/g body weight using 31-gauge syringe needle either every day or every other day. Phosphate buffered saline (PBS) was injected intraperitoneally at P26 to
Krt19
CreERT/+ ; R26 tdTOM as no tamoxifen control.
| Genetic recombination and immunofluorescence analysis
The entire spine and hind-limbs were dissected in cold PBS and fixed for 4 hours in 4% paraformaldehyde, and then washed in PBS for imaging, or were processed for cryosectioning. The spine and knee joints from 6 M old Krt19 High magnification (60×) images were deconvoluted in the NIS elements software using the Landweber algorithm and with 15
iterations.
Immunostaining was conducted on the IVDs cryosectioned in the coronal plane as previously described (Dahia et al., 2012) .
Briefly, first, the cryosections were air-dried and rehydrated in PBS. Sections were permeabilized for 20 min using 0.25% Tritonx100 prepared in PBS. Next, the sections were blocked for 1 hour at room temperature in blocking buffer (10% donkey serum [ Life Technologies). A negative control slide was also processed along with the samples and in a similar way except for not incubating with primary antibody. This negative control slide was used to determine background and exposure parameters. All samples were imaged at 10× and 60× magnifications as described above. High magnification (60×) images were deconvoluted as described above.
| Quantification of immunofluorescence data
Recombination efficiency was quantified using the NIS elements software. The nuclei were counted by defining a polygonal region of interest (ROI) around the entire NP area and then thresholding for DAPI for object count. Next, the number of mGFP+ or the number of mTOM+ NP cells within that ROI were counted manually, and these numbers were divided by the total number of nuclei to determine the percentage of recombined NP cells. As all NP cells were KRT19 immunofluorescence (IF+), the percentage of mGFP+ and mTOM+ NP cells that expressed KRT19 was calculated as described above. To determine the age-related change in KRT19 expression in the NP cells, the ROI was drawn around the entire NP area and the sum intensity for KRT19-IF was determined, CreERT/+ ; R26 mT/mG following two doses of tamoxifen treatment (+Tam ×2). All cryosections were counterstained with DAPI (blue). Images in (a-e,g-j) are captured at 10x magnification. Images in (a'-e') are captured at 60x magnification. For testing recombination, n = 2 for +Tam ×1, n = 2 +Tam ×2, n = 3 +Tam x3, n = 4 +Tam ×2 for R26mT/mG only, and n = 2 for PBS only and no Tam control. ***<0.001 ****<0.0001. One-way ANOVA with post hoc Tukey test. AF, annulus fibrosus; ANOVA, analysis of variance; DAPI, 4',6-diamidino-2-phenylindole; EP, endplate; GP, growth plate; iAF, inner annulus fibrosus; IVD, intervertebral disc; Krt19, keratin 19; NP, nucleus pulposus; oAF, outer annulus fibrosus; Tam, tamoxifen; VB, vertebral body; x, times mean ± standard error of the mean (SEM). The percentages of recombined NP cells were statistically analyzed using one-way analysis of variance using GraphPad prism version 8.0. The relevant factor in Figure 1 was the number of doses of Tam that were administered, while age was the relevant factor in Figures 2 and 3 . A significant main effect of either factor prompted Tukey post hoc analyses for multiple comparisons.
A p < .05 was considered statistically significant. To quantify data presented in Figure 3k a two-tailed t test was performed to compare the sum intensity for KRT19-IF in mGFP+ versus mTOM+ NP cells within each age cohort.
F I G U R E 2 Efficient and specific targeting of the NP cells by Krt19
CreERT allele in the IVD with age. (Muzumdar et al., 2007) . In the absence of Cre recombinase, all cells and tissues of the mouse carrying the R26 mT/mG allele express the membrane-bound tdTomato (mT or mTOM) and appear red under epifluorescence.
However, in the presence of Cre under a cell-specific promoter, recombination will cause floxing out, or targeting, the mTOM cassette, and induce the expression of membrane-bound EGFP (mG or mGFP) and now these cells will appear green under epifluorescence (Muzumdar et al., 2007 
| Krt19
CreERT allele efficiently targets NP cells in the IVDs of skeletally mature mice CreERT/+ ; R26 mT/mG mice also shows that Krt19
CreERT is specific to NP cells that were mGFP+, while the surrounding AF did not undergo recombination and continued to be mTOM+ (Figure 2e ). 
| Validation of efficiency and specificity of Krt19
CreERT to target the NP cells using an additional independent reporter allele Next, to validate the specificity of Krt19
CreERT for the NP cells in the spine, we tested the Tam-induced Krt19
CreERT mediated recombination using a different conditional reporter allele. Towards this,
Krt19
CreERT was crossed with Ai14 (R26 tdTOM ) to generate the were negative for tdTOM epifluorescence (Figure 4a,b) . In another experiment, 6 M old R26 tdTOM and Krt19 CreERT/+ ; R26 tdTOM littermates were Tam-treated (+Tam ×3). The thoracic spine from both the mice was dissected and imaged using DsRed epifluorescence and stereomicroscope (Figure 4c ). Only the nucleus pulposus from 
| The Krt19
CreERT allele is specific to the NP cells in the musculoskeletal system
When designing experiments to determine the effect of genetic manipulation in the NP cells of the IVD, it is crucial that cells from other musculoskeletal tissues including joints are not targeted, especially considering that the mouse is a quadruped and defects in the joints may, in turn, affect the spine and the IVDs. Hence, following administration of three doses of Tamoxifen (+Tam ×3), the Krt19 CreERT/+ mediated recombination of R26 tdTOM allele was analyzed in the knee joint of 6 M old mice. Figure 5a shows the thoracic spine and knee joint dissected from the same mouse and imaged together using DsRed epifluorescence and stereomicroscope. Only the NP in the spine was observed to be tdTOM+. No fluorescence signal was detected from the knee joint. Figure 5b shows the DAPI stained sagittal section of the knee joint imaged using a wide-field epifluorescence microscope equipped with darkfield imaging. No tdTOM+ cells were observed in the entire knee joint. All cells and tissues of the knee joint including tibia, femur, articular cartilage (AC), the secondary center of ossification (2°O), growth plates (GP) of these long bones, meniscus (M), tendon (T), and muscle were negative for tdTOM epifluorescence.
These results indicate that the Krt19
CreERT is exclusive to the NP CreERT/+ ; R26 tdTOM (right) mice imaged together using DsRed epifluorescence and stereoscope. For testing recombination, n = 2 at P12 (a), n = 3 at 4-6 M (b) of age. AF, annulus fibrosus; DAPI, 4',6-diamidino-2-phenylindole; EP, endplate; GP, growth plate; iAF, inner annulus fibrosus; IVD, intervertebral disc; Krt19, keratin 19; NP, nucleus pulposus; oAF, outer annulus fibrosus; Tam, tamoxifen; VB, vertebral body; x, times cells amongst the various musculoskeletal tissues analyzed in the current study.
| DISCUSSION
Results of the current study demonstrate that Tam IVD of the 12-week-old mouse (Bonavita et al., 2018) . While KRT19 was expressed by all NP cells in the sacral IVD of P4 mouse, the percentages of KRT19-IF+ cells in the sacral IVD reduced from P4 to 12-weeks of age (Bonavita et al., 2018) . Hence, the higher recombination observed in the NP cells of P7 mouse sacral IVD (Figure 1i ) in the current study is due to ubiquitous KRT19 expression at this age. Also, in the current study, Tam-induced
Krt19
CreERT mediated recombination occurred with equal efficiency in the NP cells from the IVDs of the cervical, thoracic, lumbar, sacral, and caudal region of the spine in a neonatal mouse, as KRT19 is ubiquitously expressed by NP cells at this age.
The ability to precisely target NP cells at a given time during the postnatal stages has been a limitation. The current strategy to determine loss of gene function in NP cells is either by using noninducible alleles including Noto Cre (McCann et al., 2012) , Shh
Cre (Harfe et al., 2004) , or Foxa2 Cre (Uetzmann et al., 2008) , where the recombination or targeting of conditional allele occurs at the node and early notochord stage in the embryo, which is before
CreERT driver line is specific to the NP cells and does not target other musculoskeletal tissues analyzed. (a)
Representative stereoscopic image using DsRed epifluorescence of the thoracic spine (top) and knee joint (bottom) from 6 M old tamoxifentreated Krt19
CreERT (Uetzmann et al., 2008) . And Shh Cre mediates unregulated recombination in organs arising from definitive endoderm including the bladder urothelium (Bell et al., 2011) , the epithelium of submandibular glands (Szymaniak et al., 2017) , the gastrointestinal tract (Mao, Kim, Rajurkar, Shivdasani, & McMahon, 2010) , the trachea and esophagus (Kishimoto et al., 2018) , the lung epithelium (Kadzik et al., 2014) , and the epidermal placode (Levy, Lindon, Harfe, & Morgan, 2005 (Zheng et al., 2019) . In addition to node or notochord specific alleles, the use of Tam-inducible alleles under the extracellular matrix genes including aggrecan using Agc1
CreERT2 (Henry et al., 2009; Henry, Liang, Akdemir, & de Crombrugghe, 2012) , and collagen type 2a1 using Col2a1 CreERT2 (Chen et al., 2007) are used to target NP cells in the postnatal stages (Alkhatib et al., 2018; Alvarez-Garcia et al., 2018; Chen et al., 2007; Henry et al., 2012; Liao et al., 2019; Novais et al., 2019; Zheng et al., 2018) .
However, these Tam-inducible alleles are not specific to a particular compartment of the IVD (NP, inner and outer AF or EP). In addition, these driver lines also mediate recombination of conditional alleles in cartilage including adjacent vertebral growth plate chondrocytes, AC, growth plate of long bone (Cantley et al., 2013; Henry et al., 2012; Hirai, Chagin, Kobayashi, Mackem, & Kronenberg, 2011; Maeda et al., 2007; Nagao, Cheong, & Olsen, 2016; Ono, Ono, Nagasawa, & Kronenberg, 2014; Zhou et al., 2014) , tendon and ligaments (Nagao et al., 2016) , and other cartilaginous tissues in the body including nasal capsule cartilage (Kaucka et al., 2018) . Hence, in experiments utilizing these driver lines alterations or defects in the musculoskeletal tissues and joints may, in turn, affect the posture of the mouse as well as uneven loading of the spine and the IVDs. Therefore, these inducible driver lines driven by genes that are expressed by various cartilaginous tissues are not ideal for targeting the NP cells.
Characterization of a Col1a2
CreERT allele (Bou-Gharios et al., 1996) in the three-week-old mouse IVD showed that this allele is specific for outer AF (Bedore, Quesnel, Quinonez, Seguin, & Leask, 2016) .
However, in addition to outer AF, Col1a2
CreERT is also expressed in several cells, including osteoblasts (Bou-Gharios et al., 1996) . Thus, the major caveat of the currently available Tam stomach (Means et al., 2008) , and hair follicle stem cells (Zito et al., 2014) . Hence, in addition to the NP within the IVD, Tam will also induce Krt19
CreERT mediated recombination in these tissues. Hence, in the experiments using Krt19
CreERT allele for conditional knockdown or overexpression of the genes of interest, the effects on these organs should be considered. One of the ways is to weigh the mice before
Tam administration and at the end of the experiment to determine changes in body weight compared to littermate controls. However, considering that the IVDs are the largest avascular tissues, and spatially distant from these organs, genetic manipulation in these organs having a direct effect on the NP cells is highly unlikely.
In summary, the current study demonstrates that the Krt19 whether quiescent NP cells can be targeted for reactivation of the entire disc (Bonavita et al., 2018) aimed toward disc regeneration.
